Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Cappuzzo, F
Magrini, E
Bartolini, S
Ceresoli, G
Ludovini, V
Gregorc, V
Ligorio, C
Lombardo, L
Crinò, L
机构：
[1] Bellaria Hosp, Bologna, Italy
[2] Univ Milan, Inst Hosp San Raffaele, Milan, Italy
[3] Monteluce Policlin, Perugia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3004
引用
收藏
页码：196S / 196S
页数：1
相关论文
共 50 条
  • [1] ROLE OF LOSS OF PTEN IN PHOSPHO-AKT (P-AKT) POSITIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH GEFITINIB
    Cappuzzo, Federico
    Magrini, Elisabetta
    Bartolini, Stefania
    Ludovini, Vienna
    Ceresoli, Giovanni
    Lombardo, Laura
    Gregorc, Vanesa
    Ligorio, Claudia
    Damiani, Stefania
    Crino, Lucio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 7 - 8
  • [2] GEFITINIB IN EGFR FISH POSITIVE/PHOSPHO-AKT POSITIVE AND/OR NEVER SMOKER NON-SMALL CELL LUNG CANCER (NSCLC), CLINICAL AND BIOLOGICAL EFFECTS
    Garcia-Bueno, Jose M.
    Gioseffi, Hernan
    Valls, Agustin
    Saglieti, Sara
    Mas, Jose M.
    Vera, Roberto
    Sanchez-Sanchez, J. L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1236 - S1236
  • [3] Phospho-Akt expression is associated with a favorable outcome in non-small cell lung cancer
    Shah, A
    Swain, WA
    Richardson, D
    Edwards, J
    Stewart, DJ
    Richardson, CM
    Swinson, DEB
    Patel, D
    Jones, JL
    O'Byrne, KJ
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2930 - 2936
  • [4] Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
    Kitano, Haruhisa
    Chung, Joon-Yong
    Ylaya, Kris
    Conway, Catherine
    Takikita, Mikiko
    Fukuoka, Junya
    Doki, Yoshinori
    Hanaoka, Jun
    Hewitt, Stephen M.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (05) : 335 - 346
  • [5] Clinical and biological effects of gefitinib in EGFR fish positive/phospho-AKT positive or never smoker non-small cell lung cancer (NSCLC): Results of the ONCOBELL trial
    Cappuzzo, F.
    Toschi, L.
    Trisolini, R.
    Bartolini, S.
    Magrini, E.
    Domenichini, I
    Metro, G.
    Crino, L.
    Ciardiello, F.
    Varella-Garcia, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI25 - XI25
  • [6] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    Cappuzzo, F
    Magrini, E
    Ceresoli, GL
    Bartolini, S
    Rossi, E
    Ludovini, V
    Gregorc, V
    Ligorio, C
    Cancellieri, A
    Damiani, S
    Spreafico, A
    Paties, CT
    Lombardo, L
    Calandri, C
    Bellezza, G
    Tonato, M
    Crinò, L
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) : 1133 - 1141
  • [7] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    De Braud, F
    De Pas, T
    Spaggiari, L
    Veronesi, G
    Curigliano, G
    Noberasco, C
    Pelosi, G
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 461 - 462
  • [8] The combination of phospho-AKT, phospho-MTOR, phospho-MAPK and EGFR predicts survival in non-small cell lung cancer
    Kitano, Haruhisa
    Chung, Joon-Yong
    Ylaya, Kris
    Takikita, Mikiko
    Fukuoka, Junya
    Tezuka, Noriaki
    Hewitt, Stephen M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S485 - S485
  • [9] Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: A meta-analysis
    Yang, Yang
    Luo, Jialin
    Zhai, Xiaoming
    Fu, Zhiqin
    Tang, Zhongzhu
    Liu, Luying
    Chen, Ming
    Zhu, Yuan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1417 - 1424
  • [10] Clinical and biological effects of gefitinib in EGFR FISH positive/phospho-akt positive or never smoker non-small cell lung cancer (NSCLC): Preliminary results of the ONCOBELL trial.
    Cappuzzo, F.
    Toschi, L.
    Trisolini, R.
    Bemis, L.
    Sujita, M.
    Domenichini, I.
    Franklin, W.
    Crino, L.
    Ciardiello, F.
    Varella-Garcia, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 369S - 369S
12345